{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:12:21Z","timestamp":1791868341191,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-04033-2","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T17:09:18Z","timestamp":1759165758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inflammatory status and clinical phenotypes of PCOS: the role of NLR, SII, SIRI, and AISI"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4202-1681","authenticated-orcid":false,"given":"Halis Do\u011fukan","family":"Ozkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2437-9719","authenticated-orcid":false,"given":"Merve","family":"Ayas Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8192-8841","authenticated-orcid":false,"given":"Ruken","family":"Dayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9983-2306","authenticated-orcid":false,"given":"Dilara","family":"Duygulu Bulan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6137-0270","authenticated-orcid":false,"given":"Ahmet Arif","family":"Filiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1011-3848","authenticated-orcid":false,"given":"Yaprak","family":"Engin-Ustun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"4033_CR1","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1097\/AOG.0000000000002656","volume":"131","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology","year":"2018","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology. ACOG practice bulletin 194: polycystic ovary syndrome. Obstet Gynecol. 2018;131:e157\u201371. https:\/\/doi.org\/10.1097\/AOG.0000000000002656.","journal-title":"Obstet Gynecol"},{"key":"4033_CR2","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10:668\u201380. https:\/\/doi.org\/10.1016\/S2213-8587(22)00163-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4033_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219\u201331. https:\/\/doi.org\/10.1038\/nrendo.2010.217.","journal-title":"Nat Rev Endocrinol"},{"key":"4033_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"ESHRE Rotterdam","year":"2004","unstructured":"Rotterdam ESHRE, ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41\u20137. https:\/\/doi.org\/10.1093\/humrep\/deh098.","journal-title":"Hum Reprod"},{"key":"4033_CR5","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/jcm12041454","volume":"12","author":"S Singh","year":"2023","unstructured":"Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023;12:1454. https:\/\/doi.org\/10.3390\/jcm12041454.","journal-title":"J Clin Med"},{"key":"4033_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.32322\/jhsm.1189938","volume":"6","author":"B Bayraktar","year":"2023","unstructured":"Bayraktar B, Taner CE. The effect of polycystic ovary syndrome history on neonatal anogenital distance: a prospective study in Turkish population. J Health Sci Med. 2023;6:30\u20134. https:\/\/doi.org\/10.32322\/jhsm.1189938.","journal-title":"J Health Sci Med"},{"key":"4033_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","volume":"303","author":"S Abraham Gnanadass","year":"2021","unstructured":"Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303:631\u201343. https:\/\/doi.org\/10.1007\/s00404-020-05951-2.","journal-title":"Arch Gynecol Obstet"},{"key":"4033_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1055\/a-0992-9114","volume":"128","author":"E Hatziagelaki","year":"2020","unstructured":"Hatziagelaki E, Pergialiotis V, Kannenberg JM, Trakakis E, Tsiavou A, Markgraf DF, et al. Association between biomarkers of low-grade inflammation and sex hormones in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2020;128:723\u201330. https:\/\/doi.org\/10.1055\/a-0992-9114.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"4033_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22:3789. https:\/\/doi.org\/10.3390\/ijms22073789.","journal-title":"Int J Mol Sci"},{"key":"4033_CR10","doi-asserted-by":"publisher","first-page":"R219","DOI":"10.1530\/REP-14-0435","volume":"149","author":"PM Spritzer","year":"2015","unstructured":"Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149:R219\u2013227. https:\/\/doi.org\/10.1530\/REP-14-0435.","journal-title":"Reproduction"},{"key":"4033_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.tem.2015.08.001","volume":"26","author":"C Herder","year":"2015","unstructured":"Herder C, Dalmas E, B\u00f6ni-Schnetzler M, Donath MY. The IL-1 pathway in type 2 diabetes and cardiovascular complications. Trends Endocrinol Metab. 2015;26:551\u201363. https:\/\/doi.org\/10.1016\/j.tem.2015.08.001.","journal-title":"Trends Endocrinol Metab"},{"key":"4033_CR12","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3389\/fimmu.2017.01745","volume":"8","author":"D Frasca","year":"2017","unstructured":"Frasca D, Blomberg BB, Paganelli R. Aging, obesity, and inflammatory age-related diseases. Front Immunol. 2017;8:1745. https:\/\/doi.org\/10.3389\/fimmu.2017.01745.","journal-title":"Front Immunol"},{"key":"4033_CR13","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1161\/ATVBAHA.117.309307","volume":"37","author":"C Herder","year":"2017","unstructured":"Herder C, de Las Heras Gala T, Carstensen-Kirberg M, Huth C, Zierer A, Wahl S, et al. Circulating levels of interleukin 1-receptor antagonist and risk of cardiovascular disease: meta-analysis of six population-based cohorts. Arterioscler Thromb Vasc Biol. 2017;37:1222\u20137. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309307.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4033_CR14","doi-asserted-by":"publisher","first-page":"e78350","DOI":"10.1371\/journal.pone.0078350","volume":"8","author":"J Henson","year":"2013","unstructured":"Henson J, Yates T, Edwardson CL, Khunti K, Talbot D, Gray LJ, et al. Sedentary time and markers of chronic low-grade inflammation in a high risk population. PLoS ONE. 2013;8:e78350. https:\/\/doi.org\/10.1371\/journal.pone.0078350.","journal-title":"PLoS ONE"},{"key":"4033_CR15","doi-asserted-by":"publisher","first-page":"e22711","DOI":"10.7759\/cureus.22711","volume":"14","author":"D Khanna","year":"2022","unstructured":"Khanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: a chronic low-grade inflammation and its markers. Cureus. 2022;14:e22711. https:\/\/doi.org\/10.7759\/cureus.22711.","journal-title":"Cureus"},{"key":"4033_CR16","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3324\/haematol.2016.144055","volume":"101","author":"M Bonaccio","year":"2016","unstructured":"Bonaccio M, Di Castelnuovo A, Pounis G, De Curtis A, Costanzo S, Persichillo M, et al. A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-sani study. Haematologica. 2016;101:1434\u201341. https:\/\/doi.org\/10.3324\/haematol.2016.144055.","journal-title":"Haematologica"},{"key":"4033_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030579","volume":"101","author":"L Li","year":"2022","unstructured":"Li L, Yu J, Zhou Z. Association between neutrophil-to-lymphocyte ratio and polycystic ovary syndrome: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2022;101:e30579. https:\/\/doi.org\/10.1097\/MD.0000000000030579.","journal-title":"Medicine"},{"key":"4033_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s12905-024-03405-4","volume":"24","author":"X Zhou","year":"2024","unstructured":"Zhou X, Tian Y, Zhang X. Correlation and predictive value of systemic immune-inflammation index for dyslipidemia in patients with polycystic ovary syndrome. BMC Womens Health. 2024;24:564. https:\/\/doi.org\/10.1186\/s12905-024-03405-4.","journal-title":"BMC Womens Health"},{"key":"4033_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12031128","volume":"12","author":"Y Xia","year":"2023","unstructured":"Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults. J Clin Med. 2023;12:1128. https:\/\/doi.org\/10.3390\/jcm12031128.","journal-title":"J Clin Med"},{"key":"4033_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12944-025-02589-4","volume":"24","author":"Z Su","year":"2025","unstructured":"Su Z, Cao L, Chen H, Zhang P, Wu C, Lu J, et al. Obesity indicators mediate the association between the aggregate index of systemic inflammation (AISI) and type 2 diabetes mellitus (T2DM). Lipids Health Dis. 2025;24:176. https:\/\/doi.org\/10.1186\/s12944-025-02589-4.","journal-title":"Lipids Health Dis"},{"key":"4033_CR21","doi-asserted-by":"publisher","unstructured":"Dayanan R, Filiz AA, Aktemur G, Cakir BT, Karabay G, Seyhanli Z et al. Predictive value and prognostic significance of Pan-Immune-Inflammation value, systemic Immune-Inflammation index, and systemic inflammatory response index in placenta accreta spectrum and placenta previa. Gynecol Obstet Reproductive Med 2025:1\u20138. https:\/\/doi.org\/10.21613\/GORM.2025.1587","DOI":"10.21613\/GORM.2025.1587"},{"key":"4033_CR22","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00404-022-06686-y","volume":"306","author":"J Qu","year":"2022","unstructured":"Qu J, Li B, Qiu M, Wang J, Chen Z, Li K, et al. Discovery of immune-related diagnostic biomarkers and construction of diagnostic model in varies polycystic ovary syndrome. Arch Gynecol Obstet. 2022;306:1607\u201315. https:\/\/doi.org\/10.1007\/s00404-022-06686-y.","journal-title":"Arch Gynecol Obstet"},{"key":"4033_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cca.2022.04.234","volume":"531","author":"Y-Y Luan","year":"2022","unstructured":"Luan Y-Y, Zhang L, Peng Y-Q, Li Y-Y, Liu R-X, Yin C-H. Immune regulation in polycystic ovary syndrome. Clin Chim Acta. 2022;531:265\u201372. https:\/\/doi.org\/10.1016\/j.cca.2022.04.234.","journal-title":"Clin Chim Acta"},{"key":"4033_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.5935\/1518-0557.20250014","volume":"29","author":"U Zorlu","year":"2025","unstructured":"Zorlu U, Turgay B, Y\u0131lmazer-Zorlu SN, Halilzade M\u0130, Halilzade \u0130, Yal\u00e7\u0131n HR. Investigation of the relationship between clinical features and the sonographic appearance of the ovaries with the delta neutrophil index in polycystic ovary syndrome. JBRA Assist Reprod. 2025;29:333\u20137. https:\/\/doi.org\/10.5935\/1518-0557.20250014.","journal-title":"JBRA Assist Reprod"},{"key":"4033_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40618-015-0335-2","volume":"39","author":"MA Yilmaz","year":"2016","unstructured":"Yilmaz MA, Duran C, Basaran M. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest. 2016;39:45\u201353. https:\/\/doi.org\/10.1007\/s40618-015-0335-2.","journal-title":"J Endocrinol Invest"},{"key":"4033_CR26","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/biolre\/ioab050","volume":"104","author":"LM Velez","year":"2021","unstructured":"Velez LM, Seldin M, Motta AB. Inflammation and reproductive function in women with polycystic ovary syndrome\u2020. Biol Reprod. 2021;104:1205\u201317. https:\/\/doi.org\/10.1093\/biolre\/ioab050.","journal-title":"Biol Reprod"},{"key":"4033_CR27","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"S Siddiqui","year":"2022","unstructured":"Siddiqui S, Mateen S, Ahmad R, Moin S. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39:2439\u201373. https:\/\/doi.org\/10.1007\/s10815-022-02625-7.","journal-title":"J Assist Reprod Genet"},{"key":"4033_CR28","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. J Clin Endocrinol Metab. 2010;95:2038\u201349. https:\/\/doi.org\/10.1210\/jc.2009-2724.","journal-title":"J Clin Endocrinol Metab"},{"key":"4033_CR29","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","volume":"26","author":"V Wekker","year":"2020","unstructured":"Wekker V, van Dammen L, Koning A, Heida KY, Painter RC, Limpens J, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26:942\u201360. https:\/\/doi.org\/10.1093\/humupd\/dmaa029.","journal-title":"Hum Reprod Update"},{"key":"4033_CR30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12872-023-03661-6","volume":"23","author":"N Jin","year":"2023","unstructured":"Jin N, Huang L, Hong J, Zhao X, Hu J, Wang S, et al. The association between systemic inflammation markers and the prevalence of hypertension. BMC Cardiovasc Disord. 2023;23:615. https:\/\/doi.org\/10.1186\/s12872-023-03661-6.","journal-title":"BMC Cardiovasc Disord"},{"key":"4033_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.944991","volume":"13","author":"P Wang","year":"2022","unstructured":"Wang P, Guo X, Zhou Y, Li Z, Yu S, Sun Y, et al. Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population. Front Endocrinol (Lausanne). 2022;13:944991. https:\/\/doi.org\/10.3389\/fendo.2022.944991.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4033_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1100453","volume":"14","author":"Y Song","year":"2023","unstructured":"Song Y, Zhao Y, Shu Y, Zhang L, Cheng W, Wang L, et al. Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: a cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1100453. https:\/\/doi.org\/10.3389\/fendo.2023.1100453.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4033_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1374992","volume":"11","author":"K Chen","year":"2024","unstructured":"Chen K, Li S, Xie Z, Liu Y, Li Y, Mai J, et al. Association between oxidative balance score, systemic inflammatory response index, and cardiovascular disease risk: a cross-sectional analysis based on NHANES 2007\u20132018 data. Front Nutr. 2024;11:1374992. https:\/\/doi.org\/10.3389\/fnut.2024.1374992.","journal-title":"Front Nutr"},{"key":"4033_CR34","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.1002\/fsn3.4347","volume":"12","author":"H Yang","year":"2024","unstructured":"Yang H, Liu Y, Huang Z, Deng G. The healthy eating index 2020 components contributed unequally to systemic inflammatory biomarkers: a large national cross-sectional study. Food Sci Nutr. 2024;12:7212\u201322. https:\/\/doi.org\/10.1002\/fsn3.4347.","journal-title":"Food Sci Nutr"},{"key":"4033_CR35","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1210\/clinem\/dgad590","volume":"109","author":"AL Hirschberg","year":"2024","unstructured":"Hirschberg AL. Hyperandrogenism and cardiometabolic risk in pre- and postmenopausal women-what is the evidence?? J Clin Endocrinol Metab. 2024;109:1202\u201313. https:\/\/doi.org\/10.1210\/clinem\/dgad590.","journal-title":"J Clin Endocrinol Metab"},{"key":"4033_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000494908","volume":"53","author":"R Pasquali","year":"2019","unstructured":"Pasquali R, Oriolo C. Obesity and androgens in women. Front Horm Res. 2019;53:120\u201334. https:\/\/doi.org\/10.1159\/000494908.","journal-title":"Front Horm Res"},{"key":"4033_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001.","journal-title":"Mol Metab"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04033-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-04033-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04033-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T17:09:19Z","timestamp":1759165759000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-04033-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4033"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-04033-2","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the Etlik Z\u00fcbeyde Han\u0131m Training and Research Hospital Ethics Committee (Decision No. 2024\/15\u201323 dated December 9, 2024). The study was conducted in accordance with the Declaration of Helsinki. The requirement for informed consent was waived by the ethics committee due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"463"}}